Mark Cuban-backed companies and public debut plans you must know about

3 min read | July 07, 2022 07:40 AM EDT | By Raza Naqvi

Highlights

  • The list of businesses that Mark Cuban Companies owns often attracts investors' attention.
  • There is no information on Mark Cuban Cost Plus Drug Company IPO plan.
  • Potential investors often search for the public debut plans of Mark Cuban-backed companies.

Although Mark Cuban is best known as the Dallas Mavericks owner and a Shark Tank investor, it turns out he has invested in several companies with diverse business operations. The list of businesses that Mark Cuban Companies owns or has invested in often attracts investors' attention due to the popularity of Mr Cuban.

At the age of 12, Cuban began his career as an entrepreneur by selling trash bags door to door. Cuban later opened Motley's Pub in Bloomington while he was studying, reportedly becoming a popular bar in the area.

Apart from running a basketball team, Mr Cuban is in charge of his venture capital and private equity firm, the Mark Cuban Companies, and the Mark Cuban Foundation.

Investments made by Mark Cuban Companies span from companies founded by veterans to those run by minorities or women. His holdings in the blockchain industry are expanding. Health, exercise, wholesome food, and the environment are among Cuban's further business interests.

Potential investors often search for the public debut plans of Mark Cuban-backed companies. Here's a list of companies that remain private and are on the radar of investors:

FiscalNote

FiscalNote, a top worldwide technology supplier, provides legal and policy data. The company is believed to redefine how businesses reduce risk and seize opportunities by fusing artificial intelligence (AI) skills, professional analysis, and data on laws, regulations, and international affairs.

In April, FiscalNote expressed its intention to go public by merging with Duddell Street Acquisition Corp. (NASDAQ:DSAC). The company aims to list its Class A Common Stock after merging with the special purpose acquisition company (SPAC).

If the transaction closes successfully, FiscalNote will trade under the stock symbol NOTE on New York Stock Exchange (NYSE). However, it would be worth watching how the stock opens amid uncertain market conditions.

Mark Cuban Cost Plus Drug Company

The Mark Cuban Cost Plus Drug Company (MCCPDC) provides high-quality medications at the most competitive prices. The company claims that it is transparent about drug costs so that patients pay a reasonable price.

MCCPDC prioritizes its social objective of enhancing public health as a public-benefit organization. Since its inception, the drug company gained the attention of potential investors and often looked for its initial public offering (IPO).

There is no information on Mark Cuban Cost Plus Drug Company IPO plan, and it is highly unlikely that the company will go public this year if it has a public debut plan.

Mark Cuban Cost Plus Drug Company
©2022 Kalkine Media® 

Billshark

Billshark was established in 2016 by Steven McKean, Brian Keaney, and Michael Mora to save customers’ time and money by lowering their monthly costs and locating dormant memberships.

The company reportedly aims to help consumers and small businesses save US$ 2.7 billion by 2025, and so far, it has saved them over US$ 10 million.

Mark Cuban joined Billshark as an investor and advisor in 2018, and the company continues to gain the attention of stock market enthusiasts. Since 2018, Billshark has collaborated with several financial institutions and fintech firms.

The company has not announced an IPO plan yet and interested investors will have to wait for the official announcement.

Please note, the above content constitutes a very preliminary observation or view based on digital trends and is of limited scope without any in-depth fundamental valuation or technical analysis. Any interest in stocks or sectors should be thoroughly evaluated taking into consideration the associated risks.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.